Efalizumab's Weight-Based Dosing a Clear Advantage in Overweight Patients
Thursday August 30, 2007
A review of several clilnical trials involving efalizumab (RaptivaŽ) showed that the drug was safe and effective for patients in two groups: those under 200lbs and those over 200lbs. Many ... Read More
Green Tea Shows Early Promise for Psoriasis in Animal Study
Monday August 27, 2007
Researchers at the Medical College of Georgia found that green tea helped to reduce the rapid growth of skin cells, a key feature of Psoriasis. They studied green tea ... Read More
Psoriasis Impact Extends Beyond the Patients Themselves
Saturday August 25, 2007
A recent survey in Ireland noted that half the population has a family member or friend affected by Psoriasis, a surprisingly high number considering the often quoted statistic of a ... Read More